Behandling af diabetes mellitus med biologiske laegemidler.

Claus Morten Larsen; Thomas Mandrup-Poulsen

Behandling af diabetes mellitus med biologiske laegemidler.

Claus Morten Larsen, Thomas Mandrup-Poulsen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1 Citationer (Scopus)

Abstract

Biologic therapeutics are currently not approved for the treatment of patients with type 1 and type 2 diabetes. However, promising results from recent randomized controlled studies suggest that biologic therapeutics have therapeutic potential. This article summarizes the causal steps of the pathogenesis of type 1 and type 2 diabetes which are targeted by biologic therapeutics and reviews the treatment results.
Udgivelsesdato: 2008-Jun-9

Bidragets oversatte titel	Treatment of diabetes mellitus with biologic therapeutics
Originalsprog	Dansk
Tidsskrift	Ugeskrift for læger
Vol/bind	170
Udgave nummer	24
Sider (fra-til)	2134-7
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 2008

Bibliografisk note

Keywords: Antibodies, Monoclonal; Antigens, CD3; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Immunologic Factors; Tumor Necrosis Factor-alpha

Citationsformater

@article{ce623d70acd111ddb538000ea68e967b,

title = "Behandling af diabetes mellitus med biologiske laegemidler.",

abstract = "Biologic therapeutics are currently not approved for the treatment of patients with type 1 and type 2 diabetes. However, promising results from recent randomized controlled studies suggest that biologic therapeutics have therapeutic potential. This article summarizes the causal steps of the pathogenesis of type 1 and type 2 diabetes which are targeted by biologic therapeutics and reviews the treatment results. Udgivelsesdato: 2008-Jun-9",

author = "Larsen, {Claus Morten} and Thomas Mandrup-Poulsen",

note = "Keywords: Antibodies, Monoclonal; Antigens, CD3; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Immunologic Factors; Tumor Necrosis Factor-alpha",

year = "2008",

language = "Dansk",

volume = "170",

pages = "2134--7",

journal = "Ugeskrift for l{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "24",

}

TY - JOUR

T1 - Behandling af diabetes mellitus med biologiske laegemidler.

AU - Larsen, Claus Morten

AU - Mandrup-Poulsen, Thomas

N1 - Keywords: Antibodies, Monoclonal; Antigens, CD3; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Immunologic Factors; Tumor Necrosis Factor-alpha

PY - 2008

Y1 - 2008

N2 - Biologic therapeutics are currently not approved for the treatment of patients with type 1 and type 2 diabetes. However, promising results from recent randomized controlled studies suggest that biologic therapeutics have therapeutic potential. This article summarizes the causal steps of the pathogenesis of type 1 and type 2 diabetes which are targeted by biologic therapeutics and reviews the treatment results. Udgivelsesdato: 2008-Jun-9

AB - Biologic therapeutics are currently not approved for the treatment of patients with type 1 and type 2 diabetes. However, promising results from recent randomized controlled studies suggest that biologic therapeutics have therapeutic potential. This article summarizes the causal steps of the pathogenesis of type 1 and type 2 diabetes which are targeted by biologic therapeutics and reviews the treatment results. Udgivelsesdato: 2008-Jun-9

M3 - Tidsskriftartikel

C2 - 18565296

SN - 0041-5782

VL - 170

SP - 2134

EP - 2137

JO - Ugeskrift for læger

JF - Ugeskrift for læger

IS - 24

ER -